Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concerta in Pediatric ADHD
NCT01933880Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Dec 2009
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of methylphenidate osmotic release oral system in attention deficit hyperactivity disorder (ADHD), sponsored by Janssen Pharmaceutical. Started Dec 2009; status: completed.
02
Drugs
methylphenidate osmotic release oral system
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT01933880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01933880.